Torrent Pharma shares drop 14% after reporting decline in profit in December; Sharekhan assigns buy rating, sees 24% upside from today's low
Shares of Torrent Pharma were locked in lower circuit as they declined 13 per cent to Rs 2704.80 per share in Thursday's intraday trade on the BSE.
Anticipating better growth prospects across Indian and Brazilian business, brokerage firm Sharekhan has assigned a buy rating to this pharma stock. Source: PTI